Skip to main content
Equibles

STATE STREET CORP

Position in CGTX — Cognition Therapeutics Inc

CIK 93751 BOSTON, MA
Back to CGTX Full portfolio

Position in CGTX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$401,330
+$162,323 QoQ
Shares Held
348,983
+11.0% QoQ
Ownership
0.367%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 66 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 73% Shared 0% None 27%

Common Shares in CGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. CGTX ranks #310 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in CGTX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $401,330 348,983
2026-03-31 $239,007 314,483
2025-12-31 $424,552 314,483
2025-09-30 $438,727 324,983
2025-06-30 $37,773 121,850
2025-03-31 $51,298 121,850
2024-12-31 $85,416 121,850
2024-09-30 $29,429 62,750
2024-06-30 $104,165 62,750
2024-03-31 $92,365 50,750
2023-12-31 $93,887 50,750
2023-09-30 $73,080 50,750
2023-06-30 $55,357 30,250
2023-03-31 $59,895 30,250
2022-12-31 $63,525 30,250
2022-09-30 $27,835 14,650